Industry Relations Council

The ITNS Industry Relations Council (IRC) is available to organizations that support the goals and mission of ITNS and provide products or services used in transplantation. The goal of the IRC is to provide a format to build positive relationships and foster dialogue among key industry representatives who have ties to the specialty of transplantation, to gain greater understanding of mutual areas of interest, and to further programs that benefit patients and their families, transplant nurses, and other allied healthcare professionals.  

There are three levels of partnership available, an associatean executive level, and a premier levelIRC partnership is a one-year commitment. IRC partners can designate one corporate-designated representative who will receive ITNS membership benefits, except for voting privileges and online community accessRead more about the benefits of joining the IRC and apply today. 

Thank You to Our Current IRC Partners!

Premier Level

Atara Bio1 logo 300x300

Atara Biotherapeutics, Inc.
611 Gateway Blvd, Suite 900
South San Fracisco, CA 94080
www.atarabio.com 

Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara’s lead candidate is a T-cell immunotherapy being investigated for the treatment of patients with Epstein-Barr virus associated post-transplant lymphoproliferative disease (EBV+PTLD).

CareDx logo reg tagline

CareDx
3260 Bayshore Blvd
Brisbane, CA 94005
www.caredxinc.com 

CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.

 

Executive Level

Veloxis logo RGB 300dpi

 

Veloxis Pharmaceuticals
1001 Winstead Drive, 3rd floor, Suite 310
Cary, North Carolina 27513
www.veloxis.com

Veloxis Pharmaceuticals (Veloxis) is a specialty pharmaceutical company focused on the development and commercialization of a novel product for the prevention of organ rejection in kidney transplant patients. All clinical studies including two Phase III trials, have successfully been completed and a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) in December 2013 seeking approval for the marketing and sale. Veloxis is commited to ensuring access to ENVARSUS XR regardless of a patient's insurance or financial situation. Patient Financial Support Resources

Corporate Level

 Natera Logo for ITNS

201 Industrial Rd, Ste 410
San Carlos, CA 94070
www.natera.com/prospera 

Natera is a global leader in cell-free DNA (cfDNA) testing. Our mission is to change the management of disease worldwide in women's health, oncology and organ health. Developed by our legacy in cfDNA, the Prospera test is optimized to be a precise, reliable tool for early, clinically meaningful rejection assessment.